Premium
Sustained sutimlimab response for 3 years in patients with cold agglutinin disease: A phase I, open‐label, extension trial
Author(s) -
Gelbenegger Georg,
Jaeger Ulrich,
Fillitz Michael,
D'Sa Shirley,
Cartwright Ronwyn,
Shafer Frank,
Wardecki Marek,
Wang Jennifer,
Schoergenhofer Christian,
Jilma Bernd
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18289
Subject(s) - medicine , cold agglutinin disease , rituximab , dosing , haemolysis , clinical trial , immunology , surgery , gastroenterology , autoimmune hemolytic anemia , anemia , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom